Clinical trials
Active, not recruiting Dysbiosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Florida State University | 1 |
| Mayo Clinic | 1 |
| Ohio State University | 1 |
| Oregon State University | 1 |
| Persephone Biosciences | 1 |
| University of Pennsylvania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dysbiosis | 6 |
| Inflammation | 2 |
| COVID-19 | 1 |
| Cognitive Dysfunction | 1 |
| Critical Illness | 1 |
| Endotoxemia | 1 |
| Enterocolitis, Pseudomembranous | 1 |
| Metabolic Syndrome | 1 |
| Muscle Weakness | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.